Laurel Wealth Advisors LLC Amgen Inc Transaction History

Laurel Wealth Advisors LLC

$617 Million
Q3 2024

A detailed history of Laurel Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 24,105 shares of AMGN stock, worth $7.1 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

24,105

Previous 24,243 0.57%

Holding current value

$7.1 Million

Previous $7.57 Million 2.53%

% of portfolio

1.26%

Previous 1.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $42,694 - $46,558	-138 Reduced 0.57%	24,105 $7.77 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $208,623 - $253,532	-794 Reduced 3.17%	24,243 $7.57 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $65,604 - $79,192	-244 Reduced 0.97%	25,037 $7.12 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $12,785 - $14,422	50 Added 0.2%	25,281 $7.28 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $232,643 - $288,833	-1,064 Reduced 4.05%	25,231 $6.78 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $52,281 - $61,822	-244 Reduced 0.92%	26,295 $5.84 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $79,026 - $96,320	350 Added 1.34%	26,539 $6.42 Million
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $18,093 - $22,989	79 Added 0.3%	26,189 $6.88 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $131,084 - $147,839	584 Added 2.29%	26,110 $5.89 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $28,838 - $32,092	125 Added 0.49%	25,526 $6.21 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $10,524 - $11,643	-48 Reduced 0.19%	25,401 $6.14 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $175,014 - $200,288	880 Added 3.58%	25,449 $5.73 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $808,748 - $947,547	3,810 Added 18.35%	24,569 $5.23 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $229,375 - $254,475	982 Added 4.97%	20,759 $5.06 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $151,120 - $176,106	681 Added 3.57%	19,777 $4.92 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $517,797 - $616,604	2,393 Added 14.33%	19,096 $4.39 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $9,386 - $10,438	40 Added 0.24%	16,703 $4.25 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $26,110 - $32,041	-132 Reduced 0.79%	16,663 $3.93 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $84,559 - $112,148	464 Added 2.84%	16,795 $3.41 Million
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $63,385 - $81,472	-335 Reduced 2.01%	16,331 $3.94 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $28,554 - $34,213	-164 Reduced 0.97%	16,666 $3.23 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $340,401 - $399,027	2,042 Added 13.81%	16,830 $3.1 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $145,600 - $164,123	805 Added 5.76%	14,788 $2.81 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $2.49 Million - $2.91 Million	13,983 New	13,983 $2.72 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors LLC with notifications on news.

Account

Laurel Wealth Advisors LLC Amgen Inc Transaction History